Lobe Sciences Ltd.
LOBE
CNSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.26M | -3.19M | -3.84M | -3.45M | -3.41M |
| Total Depreciation and Amortization | -- | -- | 0.00 | 20.70K | 41.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.30K | 614.40K | 2.17M | 2.10M | 2.03M |
| Change in Net Operating Assets | 1.98M | 1.56M | 940.10K | 651.20K | 885.40K |
| Cash from Operations | -1.25M | -1.01M | -734.00K | -680.00K | -446.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -755.70K | -1.23M | -- | -- | -- |
| Cash from Investing | -755.70K | -1.23M | -- | -- | -- |
| Total Debt Issued | 168.80K | 168.80K | 8.73M | 743.70K | 563.50K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 395.60K | 345.60K | 248.70K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.25M | 8.25M | 0.00 | 248.70K | -- |
| Cash from Financing | 6.26M | 6.22M | 6.39M | 712.40K | 412.70K |
| Foreign Exchange rate Adjustments | -46.30K | -27.40K | -4.60K | -17.60K | 18.80K |
| Miscellaneous Cash Flow Adjustments | 0.00 | -- | -- | -- | -- |
| Net Change in Cash | 4.21M | 3.95M | 5.65M | 14.90K | -15.10K |